Figure 2. Best overall responses in all patients in this cohort with nivolumab.
The blue lines represent the C/C genotype, the green lines represent the C/G genotype, and the red lines represent the G/G genotype of PD-L1 rs4143815. Duration of best overall responses and changes in target lesions from baseline in 50 patients who received nivolumab.